Table 1 Baseline and demographic characteristics: randomized subjects
From: Onset of analgesia with ibuprofen sodium in tension-type headache: a randomized trial
Placebo (n = 46) | IBU Na (n = 91) | IBU Mot (n = 89) | |
|---|---|---|---|
Gender, n (%) | |||
Male | 16 (34.8) | 31 (34.1) | 30 (33.7) |
Female | 30 (65.2) | 60 (65.9) | 59 (66.3) |
Race, n (%) | |||
White/Caucasian | 46 (100.0) | 88 (96.7) | 86 (96.6) |
Black | 0 | 3 (3.3) | 3 (3.4) |
Ethnicity, n (%) | |||
Non-Hispanic | 46 (100.0) | 91 (100.0) | 89 (100.0) |
Age, mean (SD), y | 39.9 (15.2) | 42.3 (14.3) | 44.8 (13.5) |
Time with recurrent headaches, mean (SD), y | 12.3 (9.0) | 12.8 (8.7) | 13.2 (7.6) |
Tension headache frequency, past 6 months, mean (SD) | 5.5 (1.7) | 5.9 (2.3) | 6.0 (2.2) |
Pain VAS, mean (SD), mm | 82.1 (9.0) | 82.1 (8.9) | 81.9 (8.4) |
Categorical pain severity, n (%) | |||
Moderately severe | 36 (78.3) | 73 (80.2) | 70 (78.7) |
Severe | 10 (21.7) | 18 (19.8) | 19 (21.3) |